Abstract:Background: Conventional cytogenetics only analyzes metaphase cells and this analysis is affected by chromosome number and quality. A large mass of metaphase or interphase cells can be detected by fluorescence in situ hybridization on chromatosome and bone marrow smears to examine the number and structure of chromatosome. Objective: To test chromosome abnormality by fluorescence in situ hybridization and compare with the results from conventional cytogenetic analysis (CCA) in myelodysplastic syndrome (MDS). Design, Time and Setting: A case analysis was conducted at the Shenzhen Hospital of Peking University from August 2006 to September 2007. Participants: Forty-eight MDS patients, who had been preliminarily diagnosed according to FAB criteria, followed up and received chromatosome examination, were enrolled at the Shenzhen Hospital of Peking University. Simultaneously, five iron deficiency anemia patients were included as controls. Bicolor probe and CEP8 SpectumAqua probe were purchased from Vysis. Methods: Bone marrow samples received CCA by R differential staining technique. Slide was prepared by direct or short-term culture method, at least 20 karyotypes in each sample. Remaining samples received fluorescence in situ hybridization. Using airdrying, fluid was prepared at the ratio of 1:2:7 (probe: water: hybrid buffer solution), dropped in the hybrid region of the slide. Red/green fluorescence hybrid signal of interphase cells were observed under a fluorescent microscope and color filter glass, 200 in each sample. Main Outcome Measures: Abnormal positive rate of bone marrow cells was measured by two techniques. Results: Of 48 MDS patients, 38 survived after 24 months of follow-up. Using CCA, karyotype abnormalities were found in 18 (37.5%) of 48 cases, among which complex karyotypes were found in 4 (8.3%) cases, a deletion of chromosome 5/a deletion of the long arm of chromosome 5 (-5/5q-) in 5 (10.4%) cases, -7/7q- in 5 (10.4%) cases, trisomy 8 in 8 (16.6%) cases, 20q- in 2 (4.6%) cases, unconsistent translocations in 3 (6.2%) cases. Fluorescence in situ hybridization detected 5q- in 2 additional cases, 7q- in 5 additional cases, -7 in 1 additional case, +8 in 12 addition cases in addition to confirming -5/5q-, -7/7q- and +8 found by CCA in 5, 5, 8 cases raising the detection rates of -5/5q-, -7nq- and +8 to 14.5%, 22.9% and 41.7%, respectively. Conclusion: The fluorescence in situ hybridization with panel probes is more sensitive and specific for detection of chromosome 5, 7, 8 abnormalities in MDS patients than that of CCA. But it cannot replace CCA, because it cannot detect the chromosome translocation. This indicates that their combination can increase the positive rate of chromosome abnormality in MDS patients.

Identification of complex chromosome abnormalities in esophageal carcinoma cells KYSE450 by multicolor fluorescence in situ hybridization

Identification of chromosome aberrations in esophageal cancer cell line KYSE180 by multicolor fluorescence in situ hybridization.

[The Application of Dual-Color Fluorescence in Situ Hybridization to the Diagnosis of Klinefelter Syndrome].

Application of Multicolor Fluorescence in Situ Hybridization to Early Diagnosis of Esophageal Squamous Cell Carcinoma

Aneuploid Analysis of Chromosomes 3, 8, 10, 20 and Y in Esophageal Squamous Cell Carcinoma

Characterization of Genetic Rearrangements in Esophageal Squamous Carcinoma Cell Lines by a Combination of M-FISH and Array-Cgh: Further Confirmation of Some Split Genomic Regions in Primary Tumors

Chromosome aberration of urine exfoliated cells to diagnose bladder neoplasm by fluorescence in situ hybridization

Cytogenetic and Fluorescence in Situ Hybridization Characterization of Clonal Chromosomal Aberrations and CCND1 Amplification in Esophageal Carcinomas

Detection of chromosome number abnormalities in lung cancer by fluorescence in situ hybridization

Characterization of Gene Rearrangements Resulted from Genomic Structural Aberrations in Human Esophageal Squamous Cell Carcinoma KYSE150 Cells.

Chromosomes 5, 7 and 8 abnormalities in myelodysplastic syndromes by using interphase fluorescence in situ hybridization

[Fluorescence in Situ Hybridization Identifies Complex Chromosomal Aberrations in Multiple Myeloma].

Multiplex Fluorescence in Situ Hybridization (M-FISH) in the Detection of Complex Karyotypic Abnormalities of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Chromosomal Aneuploidies and Combinational Fluorescence in Situ Hybridization Probe Panels Are Useful for Predicting Prognosis for Esophageal Squamous Cell Carcinoma

[Identification of Complex Chromosomal Aberrations in Acute Leukemia by Using Conventional Cytogenetics Combined with Multiplex Fluorescence in Situ Hybridization].

The Application of Fluorescence in Situ Hybridization Performed on the Decolorized G-banding Chromosomes in Detecting the Marker Chromosomes of Gastric Cancer

[Establishment and Application of Multiplex FISH in Detection of the Complex Chromosome Abnormalities in Leukemia].

Detection of Chromosomes 5 and 7 Aberrations in Myelodysplastic Syndromes Using Dual-Color Fluorescence in Situ Hybridization

Multicolor Fluorescence in Situ Hybridization and Comparative Genomic Hybridization Reveals Molecular Events in Lung Adenocarcinomas and Squamous Cell Lung Carcinomas

Detecting the abnormity of chromosomes 8 and 20 aberrations in myelodysplastic syndromes by using fluorescence in situ hybridization

Clinical Application of Multicolor Fluorescence in Situ Hybridization on Early Diagnosis of Lung Cancer